RP-001

· Recurv Pharma Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RP-001, covering 2026-03-31 to 2026-03-31. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1/2a Study of RP-001 in Participants With Advanced Malignancies [Phase 1, Phase 2]